Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Receivables (2016 - 2025)

Macrogenics (MGNX) has disclosed Change in Receivables for 14 consecutive years, with -$55.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 1157.5% to -$55.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.1 million, a 249.6% increase, with the full-year FY2025 number at $9.1 million, up 249.6% from a year prior.
  • Change in Receivables was -$55.9 million for Q4 2025 at Macrogenics, down from $56.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $56.7 million in Q3 2025 to a low of -$55.9 million in Q4 2025.
  • A 5-year average of -$485500.0 and a median of -$2.1 million in 2024 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: crashed 7257.01% in 2021, then soared 2114.77% in 2025.
  • Macrogenics' Change in Receivables stood at -$3.4 million in 2021, then surged by 1356.19% to $42.4 million in 2022, then tumbled by 135.26% to -$14.9 million in 2023, then skyrocketed by 70.28% to -$4.4 million in 2024, then plummeted by 1157.5% to -$55.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Change in Receivables are -$55.9 million (Q4 2025), $56.7 million (Q3 2025), and $2.0 million (Q2 2025).